Diuretic Therapy for Patients with Furosemide-Induced Rash

Introduction to Alternative Diuretics

For patients who develop a rash from furosemide, alternative loop diuretics such as bumetanide or torsemide should be the first-line substitution due to their similar efficacy but different chemical structures that may avoid cross-reactivity 1, 2

Bumetanide can be substituted at a dose of 0.5-1.0 mg once or twice daily (maximum 10 mg daily), with a shorter duration of action (4-6 hours) compared to furosemide 1, 2
Torsemide is another excellent alternative, starting at 10-20 mg once daily (maximum 200 mg), with a longer duration of action (12-16 hours) and better oral bioavailability than furosemide 1, 2

Chlorthalidone 12.5-25 mg once daily (maximum 100 mg), with a long duration of action (24-72 hours) 2
Hydrochlorothiazide 25 mg once or twice daily (maximum 200 mg), with 6-12 hour duration 1, 2
Metolazone 2.5 mg once daily (maximum 20 mg), which is particularly effective in patients with reduced glomerular filtration rate 1, 2
Indapamide 2.5 mg once daily (maximum 5 mg), with a 36-hour duration of action 1, 2

Spironolactone 12.5-25 mg once daily (maximum 50 mg typically, though higher doses may occasionally be used with close monitoring) 1, 3
Amiloride 5 mg once daily (maximum 20 mg) 1, 3
Triamterene 50-75 mg twice daily (maximum 200 mg) 1, 3

Sequential nephron blockade using a loop diuretic plus a thiazide diuretic can produce marked diuresis in patients with resistant edema 1, 4

Monitor electrolytes closely, especially potassium, sodium, and magnesium, as all diuretics can cause electrolyte disturbances 1, 2, 5
Check renal function regularly, particularly when initiating therapy or changing doses 3, 6
Start with low doses and titrate based on response, generally aiming for 0.5-1.0 kg weight loss daily 2, 7
Be cautious with potassium-sparing diuretics when used with ACE inhibitors or ARBs due to risk of hyperkalemia 3, 5
Monitor for signs of dehydration and hypotension, especially in elderly patients 4, 6

The goal of diuretic therapy is to eliminate clinical evidence of fluid retention using the lowest effective dose to maintain euvolemia 2, 7